Drugs / Influenza vaccination
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials · 1 met primary | ||||||
| Phase 4 | NCT07617376 | Nov 2025 → Dec 2026 expected | cardiac rhythm disease, heart failure, myocardial infarction, pulmonary embolism | Wroclaw Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT00877396 | Sep 2008 → May 2011 | influenza | McMaster University | Completed | Met primary |
| Phase 4 | NCT00222638 | Oct 2004 → May 2005 | — | University Of Perugia | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01666535 | Sep 2012 → Mar 2013 | inflammatory bowel disease | University of Calgary | Completed | No outcome recorded |
| — | NCT00822627 | Nov 2007 → Apr 2008 | influenza | University of Arizona | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT04188483 Background | Oct → Dec 2019 | — | Huazhong University of Science and Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00222638 ↗ |
| Modality | Vaccine | “influenza vaccine” PMID 20386004 ↗ Apr 2010 |
| Route | Intramuscular | “intramuscular influenza vaccination” NCT00822627 ↗ |